Thursday, October 23, 2025

11:10 AM - 11:55 AM

---

Details

Australia is at the forefront of the microbiome revolution, with homegrown companies pioneering new microbiome-based therapeutics and diagnostics. As the field rapidly evolves from discovery to clinical and commercial reality, this session explores how Australia can strengthen its global edge in microbiome science. We’ll unpack the unique journey of developing live biotherapeutic products (LBPs) and microbiome diagnostics — from clinical validation to regulatory pathways and manufacturing at scale. The panel will explore what’s driving global interest and investment, where Australia’s strengths lie, and the challenges we must overcome to grow the sector. With the global microbiome therapeutics market projected to surpass US$1 billion by 2030, now is the time to back this opportunity. Join us as we explore what it takes to turn microbiome science into a new frontier of medicine.

---

Speaker